5 Amino 1MQ (5 Amino 1 Methylquinolinium) NNMT Inhibitor 5mg Peptide Vial Proliven Labs Peptides for Fat Burning in Maryland Detailed Guide to AOD 9604 5 Amino 1MQ Research Peptide 10mg Vials for Lab Analysis AOD 9604 had six human trials and 900 participants. Phase IIa showed positive results. Then the pivotal Phase IIb failed at every dose tested. Development was terminated in 2007. The trial history is Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports